HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) All Versions of this Article: 295/2/F426    most recent 00516.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khundmiri, S. J. Articles by Lederer, E. D. Search for Related Content PubMed PubMed Citation Articles by Khundmiri, S. J. Articles by Lederer, E. D.

PTH-mediated regulation of Na⁺-K⁺-ATPase requires Src kinase-dependent ERK phosphorylation

¹Department of Medicine, University of Louisville, Louisville, Kentucky; ²Department of Physiology, University of Arizona College of Medicine, Tucson, Arizona; and ³Veterans Affairs Medical Center, Louisville, Kentucky

Submitted 5 November 2007 ; accepted in final form 4 June 2008

	ABSTRACT

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
Parathyroid hormone (PTH) inhibits Na⁺-K⁺-ATPase activity by serine phosphorylation of the ₁-subunit through ERK-dependent phosphorylation and translocation of protein kinase C (PKC). On the basis of previous studies, we postulated that PTH regulates sodium pump activity through Src kinase, PLC, and calcium-dependent ERK phosphorylation. In the present work utilizing opossum kidney cells, a model of renal proximal tubule, PTH-stimulated ERK phosphorylation and membrane translocation of PKC were prevented by inhibition of Src kinase, PLC, and calcium entry. Pharmacological inhibition of PLA₂ did not prevent PTH-stimulated ERK phosphorylation but completely prevented PKC translocation. Silencing the expression of cytosolic or calcium-independent PLA₂ also prevented PTH-mediated phosphorylation of Na⁺-K⁺-ATPase ₁-subunit and PKC without blocking ERK phosphorylation. Inhibition of Na⁺-K⁺-ATPase activity by the PLA₂ metabolites arachidonic acid and 20-hydroxyeicosatetraenoic acid was prevented by specific inhibition of PKC but not by U0126, a MEK-1 inhibitor. Transient transfection of constitutively active MEK-1 cDNA induced phosphorylation of Na⁺-K⁺-ATPase ₁-subunit and PKC, which was prevented by PLA₂ inhibition. We conclude that PTH stimulates Na⁺-K⁺-ATPase phosphorylation and decreases the activity of Na⁺-K⁺-ATPase by a sequential activation of a signaling pathway involving Src kinase, PLC, ERK, PLA₂, and PKC.

Na⁺-K⁺-ATPase ₁-subunit; parathyroid hormone; phospholipase C; extracellular signal-regulated kinase; phospholipase A₂; protein kinase C

Na⁺-K⁺-ATPase is regulated in kidney proximal tubules by several hormones through the interplay of multiple signaling cascades. Our laboratory has demonstrated that the extracellular signal-regulated kinase (ERK) plays an essential role in the regulation of the sodium pump by parathyroid hormone (PTH) (16–18, 20). PTH stimulates phosphorylation of the ₁-subunit of Na⁺-K⁺-ATPase at Ser¹¹ through an ERK-dependent pathway leading to its endocytosis via clathrin-coated vesicles (16). This pathway involves ERK-dependent protein kinase C (PKC) activation, translocation, and association with the Na⁺-K⁺-ATPase ₁-subunit (17). The signaling mechanisms involved in PTH-stimulated ERK phosphorylation and PKC activation are not well understood. We (21) have previously shown that PTH activates ERK in a biphasic fashion, initially through phosphatidylinositol 3-kinase (PI 3-kinase) and secondly through a PKC-dependent mechanism. PTH activates several other intracellular signals, including phospholipase A₂ (PLA₂) (4, 10, 31), phospholipase C (PLC) (7), Src kinase (8), and intracellular calcium (5, 24, 26), but the interaction of these other signals with ERK in PTH regulation of Na⁺-K⁺-ATPase has not been defined. In the present study, we tested whether PTH-stimulated ERK phosphorylation is dependent on one or more of these pathways.

Studies were conducted to examine the ability of PTH to phosphorylate ERK1/2 in the presence and absence of inhibitors of c-Src kinase, PLC, and PLA₂ in opossum kidney (OK) cells. We also studied the effects of these inhibitors on PTH-mediated translocation of PKC, Na⁺-K⁺-ATPase ₁-subunit phosphorylation and surface expression, and Na⁺-K⁺-ATPase activity. Our data demonstrate that PTH increases ERK1/2 phosphorylation in a manner that is Src kinase and PLC dependent. PTH-mediated ERK1/2 phosphorylation was found to be PLA₂ independent. However, ERK1/2 phosphorylation is a necessary step leading to PLA₂ stimulation, and this affects the interaction between PKC and Na⁺-K⁺-ATPase ₁-subunit.

	METHODS

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
Materials. PTH (bovine 1–34) was purchased from Bachem Biosciences (King of Prussia, PA). Polyclonal antibodies against Na⁺-K⁺-ATPase ₁-subunit (for immunoprecipitation), antibodies against phospho-PKC, and MEK-1 cDNA were purchased from Upstate Biotechnology (Waltham, MA). Monoclonal antibodies against Na⁺-K⁺-ATPase ₁-subunit (for Western blots) were purchased from Sigma-RBI (Natick, MA). Phosphoserine antibodies were purchased from Zymed (San Francisco, CA). PP2, edelfosine (ET), 20-hydroxyeicosatetraenoic acid (20-HETE), and arachidonic acid were purchased from EMD Biochemical (Gibbstown, NJ). Bromoenol lactone [BEL; a specific inhibitor of calcium-independent PLA₂ (iPLA₂)] and methyl arachidonyl fluorophosphonate [MAFP; an inhibitor of both cytosolic (cPLA₂) and iPLA₂] were purchased from Cayman Chemicals (Ann Arbor, MI). Opti-MEM, fura-2 AM, and Pluronic acid were purchased from Invitrogen (Carlsbad, CA). A biotinylation kit was purchased from Pierce (Rockford, IL). Phospho- and total ERK antibodies, horseradish peroxidase (HRP)-linked mouse secondary antibodies, and cPLA₂ and iPLA₂ small interfering (si)RNA were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Geneporter (cDNA) and Genesilencer (siRNA) transfection reagents were purchased from Gene Therapy Systems (San Diego, CA). All other chemicals were purchased from Sigma (St. Louis, MO) unless otherwise specified.

Cell culture. OK cells used in this study are a continuous cell line derived from Virginia opossum and are a widely used model for mammalian renal proximal tubule (18). Cells were maintained at 37°C in a humidified atmosphere with 5% CO₂ in minimum essential medium with Earl's salts (EMEM) supplemented with 10% (vol/vol) fetal calf serum, 100 U/ml penicillin, and 100 µg/ml streptomycin. The cells were fed twice a week and split once a week at a 1:4 ratio. All experiments were carried out using cells at 90–95% confluence. Cells grown on six-well culture plates were washed with serum-free medium 24 h before use.

Treatment with PTH. Unless otherwise stated, the cells were treated for 15 min with 100 nM PTH (1–34) at 37°C in 95% air-5% CO₂.

⁸⁶Rb uptake. Ouabain-sensitive ⁸⁶Rb uptake was measured as an index of Na⁺-K⁺-ATPase-mediated ion transport as described previously (17).

Measurement of intracellular calcium. Intracellular calcium concentration was measured using fura-2 AM, a calcium-sensitive fluorescent dye, as described previously (19). Briefly, cultured OK cells attached to the glass coverslips were loaded with fura-2 AM for 30 min at 37°C. Fura-2 AM was dissolved in 20% Pluronic F127 and then added to Krebs solution (120 mM NaCl, 4.8 mM KCl, 5.5 mM dextrose, 3.12 mM NaH₂PO₄, and 12.48 mM Na₂HPO₄). The pH was adjusted to 7.4, after which 1.2 mM MgSO₄ and 0.54 mM CaCl₂ were added slowly to avoid precipitate formation at a final concentration of 5 µM fura-2 AM and 0.04% Pluronic F127. After being loaded, the cells were washed with Krebs solution. The glass coverslip was placed on the stage of a microscope (Carl Zeiss, Thornwood, NY) equipped with a digital fluorescence imaging system (Attofluor; Atto Instruments, Rockville, MD). The cells were continuously superfused with Krebs solution and maintained at 37°C using a heated microscope stage. The emission wavelength was 520 nm. Alternating excitation wavelengths of 334 and 380 nm were used, and fluorescence was continuously quantified. To calibrate the fluorescent signal, we permeabilized the cells at the end of each experiment by adding 10 µM ionomycin to the calcium-containing superfusate to establish the maximum signal. Next, 5 mM EGTA was added to the superfusate to obtain the minimum signal. In each experiment, data were averaged from 30–40 cells. The calcium concentration was computed according to the formula supplied by the fura-2 manufacturer (Invitrogen).

Isolation of endosomes and plasma membrane. Early and late endosomes and plasma membranes were isolated by sucrose density gradient as described previously (16). Briefly, cells were incubated with PTH (100 nM) or vehicle for 15 min at 37°C. The response to PTH was stopped by washing the cells with ice-cold PBS and adding ice-cold homogenization buffer containing 250 mM sucrose and 3 mM imidazole, pH 7.4. The cells were gently homogenized using a Dounce homogenizer and centrifuged at 4°C, 3,000 g for 5 min. The supernatant was adjusted to 40.6% sucrose and was loaded (1.5 ml) at the bottom of a 5-ml centrifuge tube. To this, a 16% sucrose solution (1.5 ml) in 3 mM imidazole, 0.5 mM EDTA, and 10% sucrose (1 ml) and 1 ml of homogenization buffer was added sequentially, and then the mixture was centrifuged for 1 h at 110,000 g in a Beckman SW 50.1 rotor. Early endosomes were collected at the homogenization buffer-10% sucrose interface, late endosomes were collected from the 10–16% sucrose interface, and the plasma membrane was collected from the 16–40.6% sucrose interface. Western blots for early endosome antigen 1 (EEA1) and mannose-6-phosphate receptor were carried out to identify the early and late endosomes, respectively.

Membrane preparation. Cells were treated with 100 nM PTH (bovine 1–34) or vehicle, washed twice with PBS, and homogenized in 50 mM mannitol and 5 mM Tris (pH 7.4), and the crude membranes were prepared as described previously (18).

Biotinylation of surface proteins. Cell surface proteins were biotinylated using sulfo-NHS-LC biotin (Pierce) following treatment for 15 min with 100 nM PTH in the presence or absence of PP2, BEL, or ET according to the manufacturer's protocol with slight modifications. Briefly, after PTH treatment, cells were washed four times with phosphate-buffered saline (PBS; pH 8.0) containing 0.5 mM CaCl₂ and 1 mM MgSO₄. Cells were then incubated for 2 h at 4°C with 1 mg/ml sulfo-NHS-LC biotin in PBS. Cells were washed four times with ice-cold PBS. Unbound biotin was then quenched with 100 mM glycine in PBS for exactly 15 min. Cells were washed four times with ice-cold PBS. Cells were scraped in 50 mM mannitol, 5 mM Tris-HEPES (pH 7.4) containing 10 µl/ml protease inhibitor cocktail (Sigma) and homogenized by being passed through a 27.5-gauge needle. Crude membranes were prepared as described above and solubilized in RIPA buffer [150 mM NaCl, 50 mM Tris·HCl (pH 7.4), 5 mM EDTA, 1% (vol/vol) Triton X-100, 1% (wt/vol) sodium deoxycholate, 0.1% (wt/vol) SDS, and 10 µl/ml protease inhibitor cocktail]. Crude membranes were incubated overnight at 4°C with an equal amount of prewashed immobilized streptavidin beads (Pierce). The samples were centrifuged in a microfuge for 5 min at top speed to collect streptavidin beads. The beads were washed four times with RIPA buffer and boiled for 5 min in an equal amount of 2x Laemmli buffer. Streptavidin-bound proteins were separated by 10% SDS-PAGE, transferred to nitrocellulose membrane, and analyzed by Western blotting using anti-Na⁺-K⁺-ATPase ₁-subunit antibodies.

Western blot analysis. OK cells were treated with 100 nM PTH for 15 min in the continued presence or absence of inhibitors of Src kinase, PLC, or PLA₂. Cells were lysed in lysis buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 20 mM NaF, 1 mM EGTA, 1 mM EDTA, 10 µl/ml protease inhibitor cocktail 1, 10 µl/ml phosphatase inhibitor cocktail 1, 0.5% Nonidet P-40 (NP-40), and 1% Triton X-100. The cell lysate was homogenized by being passed a 27.5-gauge needle and centrifuged at 20,000 g at 4°C. The supernatant proteins were separated by 10% SDS-PAGE and transferred to nitrocellulose membrane. The nitrocellulose membrane was incubated in 5% milk in 20 mM Tris, 150 mM NaCl, and 0.05% Tween 20 (TTBS) at room temperature for 1 h to inhibit nonspecific binding, followed by overnight incubation at 4°C with anti-phospho-ERK or anti-PLA₂ antibodies in 5% milk or BSA in TTBS. Location of specific antibodies was detected by incubation with peroxidase-labeled secondary antibodies at 1:2,000 dilution in 5% milk in TTBS, followed by development with enhanced chemiluminescence (New England Biolabs). The blots were stripped and reprobed with total ERK or PKC antibodies to confirm equal loading of proteins. The bands imaged by chemiluminescence were scanned using a Personal Densitometer SI (Molecular Dynamics) and analyzed using ImageJ software (NIH).

Immunoprecipitation. The crude membranes were solubilized in immunoprecipitation buffer containing 20 mM Tris·HCl (pH 7.4), 150 mM NaCl, 20 mM NaF, 1 mM EDTA, 1 mM EGTA, 10 µl/ml protease inhibitor cocktail 1, 10 µl/ml phosphatase inhibitor cocktail 1, 1% Triton X-100, 0.5% NP-40, and 0.5% SDS and centrifuged at 70,000 g for 1 h in a Beckman ultracentrifuge. Na⁺-K⁺-ATPase ₁-subunit was immunoprecipitated from 100 µg of supernatant protein overnight at 4°C as described previously (16, 17). Western blotting was performed as described above.

Confocal imaging. Confocal microscopy was performed as described previously (20). Briefly, multichambered cover glass wells (Nunc) were seeded with OK cells. Cells were washed with serum-free medium 24 h before treatment with PTH. After the treatments, cells were rinsed three times with PBS containing 0.5 mM CaCl₂ and 1 mM MgCl₂, incubated in 4% paraformaldehyde in PBS for 10 min, rinsed five times with PBS, solubilized with 0.025% saponin in PBS for 15 min, incubated at 20°C with an appropriate dilution of primary antibody (1:250 in PBS-saponin for both phospho-PKC and Na⁺-K⁺-ATPase ₁-subunit antibodies), rinsed five times with PBS-saponin, and incubated at 20°C with the appropriate Alexa Fluor secondary antibody (1:1,000) conjugated to different fluorescent tags. Alexa Fluor 488 was used for identification of phospho-PKC (green), and Alexa Fluor 555 was used for identification of the Na⁺-K⁺-ATPase ₁-subunit (red). The cells were rinsed five times with PBS-saponin, incubated with 300 nM 4,6-diamidino-2-phenylindole for 5 min, rinsed three times with PBS, and mounted with 300 µl/well PBS. Images were acquired using a Zeiss confocal microscope and analyzed using LSM510 software. The images for PKC and the Na⁺-K⁺-ATPase ₁-subunit were merged in a single image to compare the cellular distribution of the two proteins.

MEK-1 transfection. Transient transfection of MEK-1 was performed as described previously (15).

Silencer RNA transfection. cPLA₂ and iPLA₂ siRNA were transfected as described previously using Genesilencer siRNA transfection reagent (20).

Protein concentration. Protein concentration was measured with the bicinchoninic acid method (Sigma) using BSA as standard.

Statistics. Data are means ± SE. All experiments were repeated at least three times unless otherwise stated. P values were calculated by ANOVA, followed by Bonferroni's analysis using Prizm software (GraphPad). A P value <0.05 was considered statistically significant.

	RESULTS

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
Role of Src kinase, PLC, PLA₂, and calcium in PTH-mediated Na⁺-K⁺-ATPase regulation. Several laboratories have demonstrated that PTH signals through activation of Src kinase, PLC, and PLA₂ and by increasing intracellular calcium transients. To determine whether these signaling pathways are involved in the regulation of Na⁺-K⁺-ATPase, we treated OK cells for 15 min with 100 nM PTH in the presence or absence of inhibitors of Src kinase (PP2, 100 nM), PLC (ET, 30 µM), PLA₂ [BEL (iPLA₂ inhibitor) or MAFP (cPLA₂ and iPLA₂ inhibitor), 1 µM], and calcium [BAPTA-AM, 20 µM; EGTA, 1 mM; or SKF-96365, 25 µM (an inhibitor of store-operated calcium channels)] and measured Na⁺-K⁺-ATPase-mediated ⁸⁶Rb uptake. As shown in Fig. 1, inhibition of Src kinase (A), PLC (A), and PLA₂ (A and B) prevented PTH-mediated inhibition of ⁸⁶Rb uptake. PTH increased intracellular calcium concentration (Fig. 1C). Chelation of intracellular calcium (BAPTA) or inhibition of store-operated calcium channels (SKF-96365) also prevented PTH-mediated inhibition of ⁸⁶Rb uptake (Fig. 1D).

View larger version (22K): [in this window] [in a new window]   Fig. 1. Effect of Src kinase, PLC, and PLA2 on parathyroid hormone (PTH) regulation of Na+-K+-ATPase-mediated 86Rb uptake. Opossum kidney (OK) cells were treated for 15 min with 100 nM PTH in the presence or absence of the Src kinase inhibitor PP2 (100 nM; A), PLC inhibitor edelfosine (ET; 30 µM; A), the calcium-independent PLA2 (iPLA2) inhibitor bromoenol lactone (BEL; 1 µM; A), the cytosolic (cPLA2) and iPLA2 inhibitor methyl arachidonyl fluorophosphonate (MAFP; 1 µM; B), or the calcium inhibitors BAPTA-AM (20 µM) or SKF-96365 (25 µM) (D). Ouabain-sensitive 86Rb uptake (A, B, and D) or intracellular calcium (C) was measured as described in METHODS. Bars represent ouabain-sensitive 86Rb uptake as means ± SE from 6 individual experiments run in triplicate (n = 6). *P < 0.05 by ANOVA followed by Bonferroni analysis.

View larger version (22K): [in this window] [in a new window]   Fig. 2. Effect of Src kinase, PLC, and PLA2 on Na+-K+-ATPase 1-subunit surface expression. A: OK cells were treated for 15 min with 100 nM PTH, and plasma membrane (PM) and early (EE) and late endosomes (LE) were prepared as described in METHODS. Proteins were separated by 10% SDS-PAGE and analyzed by Western blotting (WB) for expression of Na+-K+-ATPase 1-subunit, early endosome antigen 1 (EEA1), and ezrin. B–E: OK cells were treated for 15 min with 100 nM PTH in the presence or absence of the Src kinase inhibitor PP2 (100 nM; B), the PLC inhibitor ET (30 µM; C), the PLA2 inhibitor BEL (1 µM; D), or the calcium inhibitors BAPTA-AM (20 µM) or SKF-96365 (25 µM) (D). Cell surface proteins were biotinylated, crude membranes were prepared, and biotinylated proteins were precipitated using streptavidin beads as described in METHODS. Biotinylated proteins were subjected to 10% SDS-PAGE, transferred, and probed with anti-Na+-K+-ATPase 1-subunit antibodies. A representative Western blot is shown. Bar diagrams show arbitrary densitometry units of Na+-K+-ATPase 1-subunit as means ± SE (n = 3). *P < 0.05 by ANOVA followed by Bonferroni analysis.

View larger version (20K): [in this window] [in a new window]   Fig. 3. Effect of Src kinase, PLC, and PLA2 on PTH-stimulated Na+-K+-ATPase 1-subunit phosphorylation. OK cells were treated for 15 min with 100 nM PTH in the presence or absence of the Src kinase inhibitor PP2 (100 nM; A), the PLC inhibitor ET (30 µM; B), the PLA2 inhibitors BEL (1 µM) or MAFP (1 µM) (C), or the calcium inhibitors BAPTA-AM (20 µM) or SKF-96365 (25 µM) (D). Cells were lysed, and crude membranes were prepared as described in METHODS. Na+-K+-ATPase 1-subunit was immunoprecipitated (IP) using anti-Na+-K+-ATPase 1-subunit antibodies as described in METHODS. Immunoprecipitated proteins were subjected to 10% SDS-PAGE, transferred, and probed with anti-phosphoserine antibodies. Nitrocellulose membranes were stripped and reprobed with anti-Na+-K+-ATPase 1-subunit antibodies (data not shown). A representative Western blot is shown. Bar diagrams show arbitrary densitometry units of phosphorylated Na+-K+-ATPase 1-subunit as means ± SE (n = 3). *P < 0.05 by ANOVA followed by Bonferroni analysis.

View larger version (24K): [in this window] [in a new window]   Fig. 4. Effect of Src kinase, PLC, and PLA2 on PTH-stimulated ERK phosphorylation. OK proximal tubule cells were treated for 15 min with 100 nM PTH in the presence or absence of the Src kinase inhibitor PP2 (100 nM; A), the PLC inhibitor ET (30 µM; B), the iPLA2 inhibitor BEL (1 µM; D), the cPLA2 and iPLA2 inhibitor MAFP (1 µM; D), or the calcium inhibitors BAPTA-AM (20 µM), SKF-96365 (25 µM), or EGTA (1 mM) (E). Cells were lysed, and the lysate proteins were separated by 10% SDS-PAGE, transferred, and immunoblotted for phospho-ERK1/2. Nitrocellulose membranes were stripped and reprobed for total ERK using ERK2 antibodies. A representative blot from 3 different experiments is shown. Bar diagrams show arbitrary densitometry units as the ratio of phosphorylated to total ERK as means ± SE (n = 3). *P < 0.05 by ANOVA followed by Bonferroni analysis.

Role of Src kinase, PLC, and PLA₂ in PTH-mediated PKC translocation.

View larger version (64K): [in this window] [in a new window]   Fig. 5. Effect of Src kinase, PLC, and PLA2 on PTH-stimulated PKC translocation. OK cells were plated on 8-well confocal tissue culture plates. Cells were treated for 15 min with 100 nM PTH in the presence or absence of the Src kinase inhibitor PP2 (100 nM), the PLC inhibitor ET (30 µM), or the PLA2 inhibitor BEL (1 µM). Cells were fixed, permeabilized, stained with anti-Na+-K+-ATPase 1-subunit (red) and anti-phospho-PKC (green), and visualized using a Zeiss confocal microscope. Representative confocal pictures are shown (n = 3). Arrows show colocalization of Na+-K+-ATPase 1-subunit with phosphorylated PKC.

View larger version (16K): [in this window] [in a new window]   Fig. 6. Effect of MEK-1 transfection and PLA2 on PKC and Na+-K+-ATPase 1-subunit phosphorylation. OK cells were transiently transfected with empty vector (pUSE) or constitutively active (CA-MEK1) or wild-type MEK-1 (WT-MEK1) as described in METHODS. Cells were lysed 24 h after transfection and subjected to 10% SDS-PAGE (A–C) for Western blot analysis for phospho-ERK1/2 (A) and phospho-PKC (B). Samples from the same lysates were analyzed for Na+-K+-ATPase 1-subunit phosphorylation by immunoprecipitation as described above (C). A representative blot from 2 independent experiments is shown. Western blots are shown for phospho-ERK1/2, phospho-PKC, and phosphoserine. Nitrocellulose membranes were stripped and reprobed for total ERK, PKC, and Na+-K+-ATPase 1-subunit (n = 2).

View larger version (16K): [in this window] [in a new window]   Fig. 7. Effect of cPLA2 and iPLA2 small interfering (si)RNA on PTH-mediated regulation of Na+-K+-ATPase 1-subunit. OK cells were transiently transfected with control, cPLA2, or iPLA2 siRNA as described in METHODS. Cells were treated for 15 min with 100 nM PTH for 24 h after transfection. Cells were lysed and subjected to 10% SDS-PAGE (A and B) for Western blot analysis for phospho-ERK1/2 (A) and phospho-PKC (B). Samples from the same lysates were analyzed for Na+-K+-ATPase 1-subunit phosphorylation by immunoprecipitation as described above (C). A representative blot from 2 independent experiments is shown. Western blots are shown for phosphorylated ERK1/2, phospho-PKC, and phosphoserine. Nitrocellulose membranes were stripped and reprobed for total ERK, PKC, and Na+-K+-ATPase 1-subunit (n = 2).

View larger version (15K): [in this window] [in a new window]   Fig. 8. Effect of 20-hydroxyeicosatetraenoic acid (20-HETE) and arachidonic acid on Na+-K+-ATPase regulation. OK cells were treated for 15 min with 10 µM 20-HETE or 5 µM arachidonic acid. A: cells were lysed, and Na+-K+-ATPase 1-subunit (top) or PKC (bottom) was immunoprecipitated from crude membranes. Immunoprecipitated proteins were subjected to 10% SDS-PAGE, transferred to nitrocellulose membrane, and analyzed by Western blotting using anti-PKC or anti-Na+-K+-ATPase 1-subunit antibodies. The blots were stripped and reprobed for total Na+-K+-ATPase 1-subunit or PKC immunoprecipitated. A representative blot is shown (n = 3). B: a sample from the Na+-K+-ATPase 1-subunit immunoprecipitate was used to analyze for Na+-K+-ATPase 1-subunit phosphorylation using anti-phosphoserine antibodies. The blots were stripped and reprobed for total Na+-K+-ATPase 1-subunit immunoprecipitated. A representative blot is shown (n = 3). C: OK cells were treated for 15 min with 10 µM 20-HETE or 5 µM arachidonic acid. Cell surface proteins were biotinylated as described in METHODS. Biotinylated proteins were precipitated using streptavidin beads, separated by 10% SDS-PAGE, transferred to nitrocellulose membranes, and analyzed by Western blotting using anti-Na+-K+-ATPase 1-subunit antibodies. A representative blot from 3 independent experiments is shown (n = 3). D: OK cells were treated for 15 min with 10 µM 20-HETE or 5 µM arachidonic acid in the presence or absence of 100 nM PKC inhibitory peptide or 10 µM U0126. 86Rb uptake was measured as described in METHODS. Bars represent ouabain-sensitive 86Rb uptake as means ± SE from 6 individual experiments run in triplicate (n = 6). *P < 0.05 by ANOVA followed by Bonferroni analysis.

	DISCUSSION

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

We (17) and others (13) recently demonstrated that ERK might directly phosphorylate PKC. PKC can be directly phosphorylated by ERK1/2 on Thr⁶³⁸ (http://scansite.mit.edu/) (1, 38). However, complete PKC activation also requires phosphorylation at Thr⁴⁹⁷ and Ser⁶⁵⁷ (3, 12), which are not classic ERK phosphorylation sites since these amino acid residues lack the required subsequent proline residue. In the present work, we tested whether transfection with CA-MEK1 into native OK cells could phosphorylate PKC and Na⁺-K⁺-ATPase ₁-subunit. The results show that phosphorylation occurred in these cells but was completely blocked by an inhibitor of PLA₂. Furthermore, the data suggest that inhibition of MEK-1 by U0126 blocked PTH-mediated phosphorylation of PKC, Na⁺-K⁺-ATPase ₁-subunit, and inhibition of Na⁺-K⁺-ATPase activity. Although we cannot exclude the possibility that PTH-stimulated ERK directly phosphorylated PKC and/or Na⁺-K⁺-ATPase ₁-subunit, the data presented suggest that ERK stimulates activation and translocation of PKC through a PLA₂-dependent pathway. Arachidonic acid and 20-HETE, products of PLA₂, are known to activate and translocate PKC to the membrane in a variety of cells. For example, Lopez-Nicolas et al. (23) demonstrated that arachidonic acid directly stimulates PKC activation and translocation in MCF-7 cells, a human breast adenocarcinoma cell line. They showed that the C2 domain of PKC is important for the activation and translocation of PKC. An arachidonic acid-mediated increase of intracellular calcium resulted in binding of arachidonic acid to the calcium binding region of PKC, followed by the interaction of arachidonic acid with the C1A domain of PKC, resulting in full activation and translocation of PKC to the membrane (23). Similar results were shown by Russell and colleagues (32, 33), who demonstrated that angiotensin II- and insulin-like growth factor-I-mediated activation and translocation of PKC are dependent on arachidonic acid release in C₂C₁₂ murine myoblasts. 20-HETE also has been shown to activate and translocate PKC. 20-HETE increases phosphorylation and translocation of PKC in a manner similar to stretching in canine basilar arteries, and the effects of 20-HETE can be prevented by damping the rise of intracellular calcium using nicardipine or gadolinium, an inhibitor of stretch-activated cation channels (29). Similar results were observed by Randriamboavonjy (30) in porcine coronary arteries. A direct relationship between 20-HETE mediated-PKC activation and Na⁺-K⁺-ATPase inhibition was demonstrated by Nowicki et al. (27) in microdissected single kidney proximal tubules.

A role for PLA₂ in regulation of Na⁺-K⁺-ATPase is consistent with previous studies. Mandel and colleagues (4, 31), using the PLA₂ inhibitor BEL, demonstrated that PTH-mediated inhibition of Na⁺-K⁺-ATPase activity requires PLA₂ in rat renal proximal tubules. They also demonstrated that treating tubules with 20-HETE, a product of PLA₂ metabolism, produces an effect similar to PTH. Previous studies from our laboratory (18) confirmed the involvement of PLA₂ in PTH-mediated inhibition of Na⁺-K⁺-ATPase activity in OK cells. Arachidonic acid and 20-HETE inhibited Na⁺-K⁺-ATPase activity similarly to PTH. 20-HETE-mediated inhibition was prevented by a general PKC inhibitor calphostin-C but not by MEK inhibitor PD-98059, suggesting that PKC activation is PLA₂ dependent but not ERK dependent (18). The present data suggest that a sequential signaling mechanism is activated by PTH to regulate Na⁺-K⁺-ATPase in OK cells in which ERK1/2 is activated through a Src kinase-, PLC-, and calcium-dependent mechanism. Activation of ERK1/2 stimulates PLA₂ activation, leading to the release of 20-HETE and/or arachidonic acid. The substrates of PLA₂ then activate PKC, causing its translocation and association with Na⁺-K⁺-ATPase ₁-subunit, resulting in its phosphorylation, endocytosis, and inhibition. Our data also demonstrate that both the PLA₂ isoforms are involved in the PTH-mediated activation of PKC and regulation of Na⁺-K⁺-ATPase. However, it remains to be determined whether ERK activates cPLA₂ and/or iPLA₂ directly or indirectly. Lin et al. (22), in a classic study, showed that cPLA₂ is a substrate for MAP kinases. Phosphorylation of cPLA₂ by a MAP kinase-dependent pathway stimulated the activity of cPLA₂ in Chinese hamster ovary cells. Steer et al. (37) and Meyer et al. (25) demonstrated that iPLA₂ is regulated through PKC-dependent phosphorylation in ventricular myocytes and in human coronary artery endothelial cells. Beckett et al. (2) demonstrated that treatment of ventricular myocytes with thrombin activates iPLA₂ in an ERK-independent manner. From the present data, we cannot determine whether ERK is required for activation of cPLA₂ and/or iPLA₂. Further studies are required to identify a link between ERK and cPLA₂/iPLA₂ activation in PTH-mediated regulation of Na⁺-K⁺-ATPase. Whether ERK phosphorylation by PTH requires cross talk among Src kinase, PLC, and the intracellular calcium transients or whether each signal can individually stimulate ERK independently of the others remains to be elucidated. Data from other laboratories suggest that Src kinase activates PLC, which then signals an increase in intracellular calcium (5, 7, 8).

Previously published work (6, 11, 24, 26) demonstrates that PTH increases intracellular calcium. The present study confirms those studies and demonstrates that PTH-mediated ERK phosphorylation is partially calcium dependent. Chelation of extracellular calcium by EGTA, inhibition of store-operated calcium channel by SKF-96365, and chelation of intracellular calcium by BAPTA-AM partially suppressed ERK phosphorylation. Consistent with the requirement for ERK phosphorylation described above, EGTA, BAPTA-AM, and SKF-96365 also prevented PTH-mediated increase in Na⁺-K⁺-ATPase ₁-subunit phosphorylation. Interestingly, chelation of intracellular (BAPTA) and extracellular (EGTA) calcium by themselves decreased surface biotinylation of Na⁺-K⁺-ATPase ₁-subunit without further decreasing PTH-mediated decrease in Na⁺-K⁺-ATPase ₁-subunit surface expression. This may be due to global decreased biotinylation of proteins or increased endocytosis of Na⁺-K⁺-ATPase ₁-subunit in the absence of calcium. Treatment with BAPTA alone did not significantly change the basal Na⁺-K⁺-ATPase-mediated ⁸⁶Rb uptake, suggesting that the decrease in biotinylation may be due to the requirement of calcium for protein biotinylation. However, the reason for the decreased biotinylation remains to be studied in detail.

In conclusion, the results of this study illustrate a sequential signal transduction pathway leading from PTH receptor ligation to inhibition of Na⁺-K⁺-ATPase activity in a model of proximal tubular cells, the opossum kidney cell line. The results demonstrate that PTH stimulates ERK by a mechanism that is Src kinase, PLC, and calcium dependent but PLA₂ independent. ERK activation stimulates phosphorylation and, thus, activation of PLA₂. The lipid by-products of PLA₂ stimulate activation and translocation of PKC, leading to enhanced association with Na⁺-K⁺-ATPase ₁-subunit. This association facilitates subsequent phosphorylation of Na⁺-K⁺-ATPase ₁-subunit, reduction in the amount of Na⁺-K⁺-ATPase ₁-subunit at the cell surface, and thus reduction in sodium pump function.

	GRANTS

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 
This work was supported by a Veteran Affairs Merit Review grant (to E. D. Lederer), American Heart Association Scientist Development Grant 0435153N and American Heart Association, Ohio Valley Affiliate Postdoctoral Fellowship Grant 0120318B (to S. J. Khundmiri), National Eye Institute Grant EY040414 (to N. A. Delamere), and a Project Grant from the J. Graham Brown Cancer Center, University of Louisville (to N. A. Delamere).

	ACKNOWLEDGMENTS

 
We are grateful to Dr. D. Mochly-Rosen, Stanford University School of Medicine, Stanford, CA, for the gift of PKC isoform-specific inhibitory peptides. We thank Nina Lesousky and Sudarshana Sengupta for expert technical assistance.

	FOOTNOTES

 

Address for reprint requests and other correspondence: S. J. Khundmiri, Kidney Disease Program, Univ. of Louisville, 570 S. Preston St., Louisville, KY 40202 (e-mail: syed.khundmiri{at}louisville.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

	REFERENCES

TOP ABSTRACT METHODS RESULTS DISCUSSION GRANTS REFERENCES

 

1. Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P. The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Calpha. Biochim Biophys Acta 1640: 85–96, 2003.[Medline]
2. Beckett CS, Pennington K, McHowat J. Activation of MAPKs in thrombin-stimulated ventricular myocytes is dependent on Ca²⁺-independent PLA₂. Am J Physiol Cell Physiol 290: C1350–C1354, 2006.[Abstract/Free Full Text]
3. Bornancin F, Parker PJ. Phosphorylation of protein kinase C- on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J Biol Chem 272: 3544–3549, 1997.[Abstract/Free Full Text]
4. Derrickson BH, Mandel LJ. Parathyroid hormone inhibits Na⁺-K⁺-ATPase through G_q/G₁₁ and the calcium-independent phospholipase A₂. Am J Physiol Renal Physiol 272: F781–F788, 1997.[Abstract/Free Full Text]
5. Friedman PA, Coutermarsh BA, Kennedy SM, Gesek FA. Parathyroid hormone stimulation of calcium transport is mediated by dual signaling mechanisms involving protein kinase A and protein kinase C. Endocrinology 137: 13–20, 1996.[Abstract]
6. Fujimori A, Miyauchi A, Hruska KA, Martin KJ, Avioli LV, Civitelli R. Desensitization of calcium messenger system in parathyroid hormone-stimulated opossum kidney cells. Am J Physiol Endocrinol Metab 264: E918–E924, 1993.[Abstract/Free Full Text]
7. Gentili C, Boland R, de Boland AR. PTH stimulates PLCβ and PLC isoenzymes in rat enterocytes: influence of ageing. Cell Signal 13: 131–138, 2001.[CrossRef][Web of Science][Medline]
8. Gentili C, Boland R, de Boland AR. Implication of Gβ proteins and c-Src tyrosine kinase in parathyroid hormone-induced signal transduction in rat enterocytes. J Endocrinol 188: 69–78, 2006.[Abstract/Free Full Text]
9. Gentili C, Morelli S, Boland R, de Boland AR. Parathyroid hormone activation of MAP kinase in rat duodenal cells is mediated by 3',5'-cyclic AMP and Ca²⁺. Biochim Biophys Acta 1540: 201–212, 2001.[Medline]
10. Gentili C, Morelli S, de Boland AR. PTH and phospholipase A₂ in the aging process of intestinal cells. J Cell Biochem 93: 312–326, 2004.[CrossRef][Web of Science][Medline]
11. Goligorsky MS, Loftus DJ, Hruska KA. Cytoplasmic calcium in individual proximal cells in culture. Am J Physiol Renal Fluid Electrolyte Physiol 251: F938–F944, 1986.[Abstract/Free Full Text]
12. Gysin S, Imber R. Phorbol-ester-activated protein kinase C- lacking phosphorylation at Ser657 is down-regulated by a mechanism involving dephosphorylation. Eur J Biochem 249: 156–160, 1997.[Web of Science][Medline]
13. Hansara G, Garcia-Paramio P, Prevostel C, Whelan RDH, Bornancin F, Parker P. Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes. Biochem J 342: 337–344, 1999.[CrossRef][Web of Science][Medline]
14. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228: 134–142, 2003.[Abstract/Free Full Text]
15. Khundmiri SJ, Amin V, Henson J, Lewis J, Ameen M, Rane MJ, Delamere NA. Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway. Am J Physiol Cell Physiol 293: C1171–C1180, 2007.[Abstract/Free Full Text]
16. Khundmiri SJ, Bertorello AM, Delamere NA, Lederer ED. Clathrin-mediated endocytosis of Na⁺,K⁺-ATPase in response to parathyroid hormone requires ERK-dependent phosphorylation of Ser-11 within the alpha1-subunit. J Biol Chem 279: 17418–17427, 2004.[Abstract/Free Full Text]
17. Khundmiri SJ, Dean WL, McLeish KR, Lederer ED. Parathyroid hormone-mediated regulation of Na⁺-K⁺-ATPase requires ERK-dependent translocation of protein kinase C alpha. J Biol Chem 280: 8705–8713, 2005.[Abstract/Free Full Text]
18. Khundmiri SJ, Lederer ED. PTH and DA regulate Na-K ATPase through divergent pathways. Am J Physiol Renal Physiol 282: F512–F522, 2002.[Abstract/Free Full Text]
19. Khundmiri SJ, Metzler M, Ameen M, Amin V, Rane MJ, Delamere NA. Ouabain induces cell proliferation through calcium-dependent activation of PKB (Akt) in opossum kidney proximal tubule cells. Am J Physiol Cell Physiol 291: C1247–C1257, 2006.[Abstract/Free Full Text]
20. Khundmiri SJ, Weinman EJ, Steplock D, Cole J, Ahmad A, Baumann PD, Barati M, Rane MJ, Lederer ED. Parathyroid hormone regulation of Na⁺, K⁺-ATPase requires the PDZ 1 domain of sodium hydrogen exchanger regulatory factor-1 in opossum kidney cells. J Am Soc Nephrol 16: 2598–2607, 2005.[Abstract/Free Full Text]
21. Lederer ED, Sohi SS, McLeish KR. Parathyroid hormone stimulates extracellular signal-regulated kinase (ERK) activity through two independent signal transduction pathways: role of ERK in sodium-phosphate cotransport. J Am Soc Nephrol 9: 975–985, 2000.
22. Lin L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA₂ is phosphorylated and activated by MAP kinase. Cell 72: 269–278, 1993.[CrossRef][Web of Science][Medline]
23. Lopez-Nicolas R, Lopez-Andreo MJ, Marin-Vicente C, Gomez- Fernandez JC, Corbalan-Garcia S. Molecular mechanisms of PKC localization and activation by arachidonic acid. The C2 domain also plays a role. J Mol Biol 357: 1105–1120, 2006.[CrossRef][Web of Science][Medline]
24. Mahon MJ, Segre GV. Stimulation by parathyroid hormone of a NHERF-1-assembled complex consisting of the parathyroid hormone I receptor, phospholipase Cbeta, and actin increases intracellular calcium in opossum kidney cells. J Biol Chem 279: 23550–23558, 2004.[Abstract/Free Full Text]
25. Meyer MC, Kell PJ, Creer MH, McHowat J. Calcium-independent phospholipase A₂ is regulated by a novel protein kinase C in human coronary artery endothelial cells. Am J Physiol Cell Physiol 288: C475–C482, 2005.[Abstract/Free Full Text]
26. Miyauchi A, Dobre V, Rickmeyer M, Cole J, Forte L, Hruska KA. Stimulation of transient elevations in cytosolic Ca²⁺ is related to inhibition of P_i transport in OK cells. Am J Physiol Renal Fluid Electrolyte Physiol 259: F485–F493, 1990.[Abstract/Free Full Text]
27. Nowicki S, Chen SL, Aizman O, Cheng XJ, Li D, Nowicki C, Nairn A, Greengard P, Aperia A. 20-Hydroxyeicosa-tetraenoic acid (20-HETE) activates protein kinase C. Role in regulation of Na⁺,K⁺ ATPase. J Clin Invest 99: 1224–1230, 1997.[Web of Science][Medline]
28. Obara K, Koide M, Nakayama K. 20-Hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilar artery via PKC-mediated inhibition of K_Ca channel. Br J Pharmacol 137: 1362–1370, 2002.[CrossRef][Web of Science][Medline]
29. Pedemonte CH, Efendiev R, Bertorello AM. Inhibition of Na,K-ATPase by dopamine in proximal tubule epithelial cells. Semin Nephrol 25: 322–327, 2005.[CrossRef][Web of Science][Medline]
30. Randriamboavonjy V, Kiss L, Falck JR, Busse R, Fleming I. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. Cardiovasc Res 65: 487–494, 2005.[Abstract/Free Full Text]
31. Ribeiro CM, Dubay GR, Falck JR, Mandel LJ. Parathyroid hormone inhibits Na⁺-K⁺-ATPase through a cytochrome P-450 pathway. Am J Physiol Renal Fluid Electrolyte Physiol 266: F497–F505, 1994.[Abstract/Free Full Text]
32. Russell ST, Eley H, Tisdale MJ. Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I). Cell Signal 19: 1583–1595, 2007.[CrossRef][Web of Science][Medline]
33. Russell ST, Wyke SM, Tisdale MJ. Mechanism of induction of muscle protein degradation by angiotensin II. Cell Signal 18: 1087–1096, 2006.[CrossRef][Web of Science][Medline]
34. Sneddon WB, Friedman PA. β-Arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type I receptor internalization. Endocrinology 148: 4073–4079, 2007.[Abstract/Free Full Text]
35. Sneddon WB, Liu F, Gesek FA, Friedman PA. Obligate mitogen-activated protein kinase activation in parathyroid hormone stimulation of calcium transport but not calcium signaling. Endocrinology 141: 4185–4193, 2000.[Abstract/Free Full Text]
36. Sneddon WB, Yang Y, Ba J, Harinstein LM, Friedman PA. Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells. Am J Physiol Renal Physiol 292: F1028–F1034, 2007.[Abstract/Free Full Text]
37. Steer SA, Wirsig KC, Creer MH, Ford DA, McHowat J. Regulation of membrane-associated iPLA₂ activity by a novel PKC isoform in ventricular myocytes. Am J Physiol Cell Physiol 283: C1621–C1626, 2002.[Abstract/Free Full Text]
38. Yaffe MB, Leparc GG, Lai J, Obata T, Volinia S, Cantley LC. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol 19: 348–353, 2001.[CrossRef][Web of Science][Medline]
39. Zhang Y, Norian JM, Magyar CE, Holstein-Rathlou NH, Mircheff AK, McDonough AA. In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition. Am J Physiol Renal Physiol 276: F711–F719, 1999.[Abstract/Free Full Text]

This article has been cited by other articles:

				Y.-C. Chen, R. K. Meier, S. Zheng, S. J. Khundmiri, M. T. Tseng, E. D. Lederer, P. N. Epstein, and B. J. Clark Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules Am J Physiol Renal Physiol, August 1, 2009; 297(2): F380 - F388. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 295/2/F426    most recent 00516.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khundmiri, S. J. Articles by Lederer, E. D. Search for Related Content PubMed PubMed Citation Articles by Khundmiri, S. J. Articles by Lederer, E. D.